Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Spinal Muscular Atrophy (SMA) Treatment
1.2 Key Market Segments
1.2.1 Spinal Muscular Atrophy (SMA) Treatment Segment by Type
1.2.2 Spinal Muscular Atrophy (SMA) Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Spinal Muscular Atrophy (SMA) Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Spinal Muscular Atrophy (SMA) Treatment Market Competitive Landscape
3.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Manufacturers (2019-2024)
3.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Spinal Muscular Atrophy (SMA) Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Spinal Muscular Atrophy (SMA) Treatment Sales Sites, Area Served, Product Type
3.6 Spinal Muscular Atrophy (SMA) Treatment Market Competitive Situation and Trends
3.6.1 Spinal Muscular Atrophy (SMA) Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Spinal Muscular Atrophy (SMA) Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Spinal Muscular Atrophy (SMA) Treatment Industry Chain Analysis
4.1 Spinal Muscular Atrophy (SMA) Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Spinal Muscular Atrophy (SMA) Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Spinal Muscular Atrophy (SMA) Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Type (2019-2024)
6.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Spinal Muscular Atrophy (SMA) Treatment Price by Type (2019-2024)
7 Spinal Muscular Atrophy (SMA) Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Sales by Application (2019-2024)
7.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Spinal Muscular Atrophy (SMA) Treatment Sales Growth Rate by Application (2019-2024)
8 Spinal Muscular Atrophy (SMA) Treatment Market Segmentation by Region
8.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Region
8.1.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales by Region
8.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Spinal Muscular Atrophy (SMA) Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Spinal Muscular Atrophy (SMA) Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Spinal Muscular Atrophy (SMA) Treatment Basic Information
9.1.2 Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Overview
9.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Spinal Muscular Atrophy (SMA) Treatment SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Isis Pharmaceuticals
9.2.1 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Basic Information
9.2.2 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Overview
9.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Market Performance
9.2.4 Isis Pharmaceuticals Business Overview
9.2.5 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment SWOT Analysis
9.2.6 Isis Pharmaceuticals Recent Developments
9.3 Biogen Idec
9.3.1 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Basic Information
9.3.2 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Overview
9.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Market Performance
9.3.4 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment SWOT Analysis
9.3.5 Biogen Idec Business Overview
9.3.6 Biogen Idec Recent Developments
9.4 Boehringer Ingelheim
9.4.1 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Basic Information
9.4.2 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Overview
9.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Market Performance
9.4.4 Boehringer Ingelheim Business Overview
9.4.5 Boehringer Ingelheim Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Basic Information
9.5.2 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Overview
9.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Regeneron Pharmaceuticals
9.6.1 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Basic Information
9.6.2 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Overview
9.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Market Performance
9.6.4 Regeneron Pharmaceuticals Business Overview
9.6.5 Regeneron Pharmaceuticals Recent Developments
10 Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Region
10.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast
10.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Region
10.2.4 South America Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Spinal Muscular Atrophy (SMA) Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Spinal Muscular Atrophy (SMA) Treatment by Type (2025-2030)
11.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Spinal Muscular Atrophy (SMA) Treatment by Type (2025-2030)
11.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Sales (K Units) Forecast by Application
11.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings